Selective Laser Trabeculoplasty versus Argon Laser Trabeculoplasty in Glaucoma Patients Treated Previously with 360° Selective Laser Trabeculoplasty: A Randomized, Single-Blind, Equivalence Clinical Trial.

[1]  Philip P. Chen,et al.  Primary Open-Angle Glaucoma Preferred Practice Pattern®. , 2020, Ophthalmology.

[2]  P. Harasymowycz,et al.  The effect of repeat 360-degree selective laser trabeculoplasty on intraocular pressure control in open-angle glaucoma. , 2016, Journal francais d'ophtalmologie.

[3]  Leonard K. Seibold,et al.  Selective Laser Trabeculoplasty: An Update , 2016, Asia-Pacific journal of ophthalmology.

[4]  C. Hutnik,et al.  Secretion of matrix metalloproteinase‐3 by co‐cultured pigmented and non‐pigmented human trabecular meshwork cells following selective laser trabeculoplasty , 2015, Clinical & experimental ophthalmology.

[5]  W. Hodge,et al.  A Randomized Clinical Trial of Selective Laser Trabeculoplasty Versus Argon Laser Trabeculoplasty in Patients With Pseudoexfoliation , 2015, Journal of glaucoma.

[6]  R. Fechtner,et al.  Long Term Efficacy of Repeat Selective Laser Trabeculoplasty , 2014, Journal of ophthalmic & vision research.

[7]  T. Realini,et al.  Repeatability of selective laser trabeculoplasty , 2014, British Journal of Ophthalmology.

[8]  M. Ayala.  Intraocular pressure reduction after initial failure of selective laser trabeculoplasty (SLT) , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  A. Wells,et al.  Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma , 2013, International Ophthalmology.

[10]  C. Hutnik,et al.  SLT and Adjunctive Medical Therapy: A Prediction Rule Analysis , 2011, Journal of glaucoma.

[11]  J. Martone,et al.  Repeat Selective Laser Trabeculoplasty , 2009, Journal of glaucoma.

[12]  C. Hutnik,et al.  Development of a Prediction Rule to Estimate the Probability of Acceptable Intraocular Pressure Reduction After Selective Laser Trabeculoplasty in Open-angle Glaucoma and Ocular Hypertension , 2008, Journal of glaucoma.

[13]  C. Birt.  Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. , 2007, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[14]  W. Hodge,et al.  Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial , 2006, British Journal of Ophthalmology.

[15]  W. Hodge,et al.  Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial , 2005, British Journal of Ophthalmology.

[16]  R. Noecker,et al.  Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. , 2001, Ophthalmology.

[17]  S. Asrani,et al.  Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With Glaucoma , 2000, Journal of glaucoma.

[18]  W. Hodge,et al.  Selective laser trabeculoplasty vargon laser trabeculoplasty: a prospective randomised clinical trial , 1999, The British journal of ophthalmology.

[19]  D. Shin,et al.  Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. , 1998, Ophthalmology.

[20]  M. Latina,et al.  Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. , 1995, Experimental eye research.

[21]  R. Olson,et al.  Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. , 2009, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.